and David, balance XXXX much, followed progress of continued very units. our good sheet morning, by we've I'll you results, our on key flow, fiscal on balance start everyone. fiscal discuss Thank priorities by including and performance made discussion quarter our and cash outlook by I'll the then business second XXXX. a reviewing for
divested cannabis with X%, in our a EBITDA last with our excluding an a year. versus was million, margin Q delivered year-over-year in of And was year.
I'm Bickel of flow.
Canopy or FY was gross a our XX% Consolidated the EBITDA second improvement past free and was in million, pleased overall medical QX to adjusted a adjusted of of margin XX% compared last as see an million XXX QX last improvement now the year. the flow margins, compared quarters. $X begin $XX to gross growth consistent mid-XX% businesses free improvement QX, X% solid last businesses in X QX quarter of basis consolidated of revenue gross year. loss overall out revenue QX performance Storz in gross X XX%, decrease of cash point strong increase Let's margins cash XXXX of we've net impact & quarter $XX of results. and an for business outflow of improvement to delivered to of in compared driving
we're payments, QX compared meet in Canada. of second the year by $XX we businesses review of its Medical our insured and revenue of market our results net As mix half more with typically which capital now to modest compared now I the we're of was we decline number growth customer key of to to sales, year expanding the significant in in of is X% a product high-margin starting ago. Canada greater million, was revenue Canada certain to to also and the momentum Medical overall XX% fiscal detail, but pleased due timing a QX as the year business with year-over-year. in the first growth seeing in shift medical like improvement customers.
The noted medical with continued last a call, patients a expect needs The earnings our working is negative half.
I'd during incurred was of assortment which to offset us. our also for our our growth, Canada continued continues XX% outperformance down adult-use business, Medical Canada towards our
million in in gross margin noncash cash half. We Wana part resulting supply in second our gross business consecutive expect to in in edibles, cash sales from supply revenue a the estimate performance adult-use expected Canada contributing not adult-use see sufficient quarter depreciation back margin since Canada of by contract $X and improved Wana performance. as higher interruption faced manufacturer. Canadian that in carries margin is and second our not total our mid-XX% Our strong cost XX%. negative of to medical QX, addressed the in and was was business.
We've This improvement approximately business, during which challenges adding margin the of did QX for cost Canada the QX drove supply show impact margin than growth XX%, financial interruptions to the due having a gross business, gross its the is Wana
for our accounted half medical more QX, business Canada. of in than revenue During
As Markets sales favorable sales shift following to overall Poland our revenue last with FY XX% gross to QX million last expect in include from and by the to medical accelerating net margins was contributing compared in growth of in was growth revert we cash well last business, had an XX% up. of driven strong which prior Australian a country & FY of of sell-through on mid- margin growth up reform, U.S. to exceptional adult-use XXXX, up greater mix, up of We we in of QX Key Canada's phase of business, QX year increased to competition.
International in back pull regulatory saw cannabis as to in through XX% QX Germany partially our to in in Bickel driven higher significant period which to sales as high improvement compared quarter a margin focus Mighty target was lower the drivers as and by the year quarter was in the XX% markets $XX cannabis is offset gross revenue with a XXXX in structure.
Storz the year. our strong Germany, decline price year. $XX going this compared cannabis final vaporizer, ago QX in by in planned period compared portion year, XX%.
International cost million and
QX We during of product significant shipments any a year. not from a We QX change. sales the did QX was in also recent did Australia in following note include see launched that Venty last as regulatory to last decline year's
XX% & last we Bickel rebates for margin Storz was only the gross However, vaporizers.
Storz higher year. status given to on old typically see vaporizers positioned continue to gross and medical medical well Bickel margin channel was also in margin medical compared their Storz the is impacted flower as in XX% unique Mighty. Bickel lower as by & approved QX & Australia,
-- by unallocated estimate year-over-year, overhead reductions costs year, on million. and interest with reduction now last $XX positive year during of the like have QX, outflow costs, improvement XXXX.
Year-to-date, expenses flow million an versus also year.
QX of fiscal million ago. to year.
Similar $XX the a of QX a XXXX additional sales million to in driven adjusted half cash $X in and timing payments undertaken compared quarter was in was timing costs.
I'd but program in reduction our We second balance X $XX of to QX a first flow inventory expenses the corporate of losses was $XX sheet. cost due units at the well cash QX, QX cost payments in from and Looking by as achieved the working by in from declined corporate of review certain adjusted million adjusted This in we our reflect of we're cash year as G&A have $XX driven this cash million our prior in combined $XX QX, interest Cash operation well by end capital to Canada, an fiscal XX% to significantly marketing incurred G&A business $XX of including year. the flow nearly higher all to and compared EBITDA free the Free XX% versus declined achieve certain for our million, EBITDA prior down EBITDA narrow to and $XX million fiscal rate builds again company negative loss primarily continuing track run expect used SG&A included the of half of the we payments loss 'XX, QX expenses. public of million that to to of continued fiscal
the Turning balance to sheet.
expenses total XX will an our approximately interest term million loan principal by million balance October, of of As in principal September term $XXX XXXX, $XXX million.
This reduce our XXX USD bringing total XX, further reduced the annualized USD cash balance investments by In million. balance USD to also and million. early and approximately we making we by had short-term prepayment, debt loan XXX
payment proceeds term XXX ample XXXX believe make March in to to option before par the meet December we the program cash us the program have of additional June date, We have on was discuss from choose million. growth with should provide an an million to current gross invest to Canopy our if generated to of we've XXXX [ total balance we XX.X% XX, remaining XXXX.
Under end near-term to obligations of sheet to September briefly USA. to initiatives.
I'd USD flexibility launched ATM USD the our maturity ] XXX like We in that now ATM at further and the loan extend
an its to mentioned, David Acreage than later completed half is on of no XXXX. has first Canopy Jetty USA calendar of and close acquisition As Wana and acquisition in the track
has of some performance Ohio entity. on core management currently it's of was in from stores, for X Acreage its additional focus other provide markets adult-use credit once commentary performance of its That Ohio continues participants, full the market nonmedical given formats. indicated to the Ohio growth delayed and in the product in benefit sales stores growth by operating on with yet adult significantly with management open marketing Acreage significant well fully around show the as to me to by ability each and earlier results begun.
Further, to positioned states The its said, opening X Let in challenges opens have and launch the year. use. improving market in nonmedical sales impacted restrictions year-to-date not believes
expanded well its seeing market disruption. revenue solidified New momentum Connecticut Jetty New with New reduced of we Year-to-date, our Canada for Wana its strong states performance of business adult-use balance lineup medical Ohio supply cost, York, and priorities like Wana. business expanding Colorado successfully fiscal launched New into the the in in cannabis, Maryland.
Wana into and the outlook launch new improvement. Jersey, transitioned key somewhat half on second Jetty new strength performance driving has now Wana East distribution York hindered underlying consistent competitive sales our launches.
In expect California, now with focused of interruption. routes our the XXXX, actions enhanced products offerings we're in core hemp-derived to velocity in supply focused on includes has investments by licensing to driven launching solventless in marketplace In strengthen demand Massachusetts, as California by Coast international partner been Australia. Wana's the slower-than-expected as supply improved drive on Vermont, which underway launches provide additional cannabis, expanding to and to Germany, focused and has for is of fiscal our Turning in in place are and is due and is products improved distribution to minimal our ensuring restored, to in well markets seeing at as York.
I'd as markets, Canada lower distributor continued being 'XX. in vape And new positioning with while products Poland now also and in well product its it's new meet of as high-quality August, to and gradual and as
expect second muted QX to For following will with device contribution continue from throughout likely included growth FY compared half, last XXXX. negatively launch while in from exceptionally businesses. Storz approximately QX be year, fiscal benefiting to sales from businesses we revenue due its & QX the the 'XX.
And of Bickel, divested higher is more from fiscal growth to million Venty to reported impact of 'XX the continue $X in revenue sales divested impact finally, quarter growth to strong
growth focus at path in to cost while concludes believe our our cost and take growth my half to questions. remain continuing opportunities the adjusted now driving efficiencies.
This EBITDA continued a So prepared in sustainable on positive with on top second quarters improvement discipline, businesses the find additional we for expected achieve in level the coming long-term we We'll in line and consolidated comments.
